HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
27277studies shown
Showing 3,529-3,540 of 27,277
Behavioral study icon
RecruitingNCT06484387

Social interaction patterns in people with schizophrenia and healthy adults

About this title

Study of Intra- and Interpersonal Multimodal Synchronizations in a Social Interaction in Individuals with a Diagnosis of Schizophrenia.

Read the official source — NCT06484387
Official study title

Study of Multimodal Intra- and Interpersonal Synchronizations in Social Interaction in Individuals with a Diagnosis of Schizophrenia.

In Montpellier
SchizophreniaBehavioural studyAges 18–60
Countries
France
Sponsor
University Hospital, Montpellier
Drug study icon
RecruitingNCT06480383

ITI-1284 or placebo added to ongoing treatment for anxiety

About this title

Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder

Read the official source — NCT06480383
Official study title

A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder Who Have an Inadequate Response to Generalized Anxiety Disorder Treatment

Multiple locations, including Glendale
AnxietyMedication study
Countries
United States, Bulgaria, Czechia, + 2 others
Sponsor
Intra-Cellular Therapies, Inc.
Drug study icon
RecruitingNCT06701903

ITI-1284 alone for generalized anxiety after limited treatment response

About this title

Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder

Read the official source — NCT06701903
What is this study about?

Researchers are comparing ITI-1284 10 mg, ITI-1284 20 mg and placebo to find out how the approaches affect anxiety symptoms in people with an anxiety condition.

Multiple locations, including Birmingham
AnxietyMedication studyAges 18+
Countries
United States, Bulgaria, Poland, + 2 others
Sponsor
Intra-Cellular Therapies, Inc.
Behavioral study icon
RecruitingNCT06036316

Language and memory skills in people with psychosis-related experiences

About this title

Study of Language Disorders and Interactions Between Mnesic Capabilities and Semantic Competencies in Patients With Psychosis

Read the official source — NCT06036316
Official study title

Study of Language Disorders and Interactions Between Mnesic Capabilities and Semantic Competencies in Patients With Psychosis

In Laxou
SchizophreniaBehavioural studyAges 16–55
Countries
France
Sponsor
Centre Psychothérapique de Nancy
Drug study icon
RecruitingNCT05850689

Lumateperone or placebo added to antidepressant treatment for major depression

About this title

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Read the official source — NCT05850689
What is this study about?

This study evaluates the safety and effectiveness of Lumateperone for people with depression.

Multiple locations, including Huntsville
DepressionMedication studyAges 18–65
Countries
United States, France, Bulgaria, + 4 others
Sponsor
Intra-Cellular Therapies, Inc.
Behavioral study icon
RecruitingNCT00018057

Neuro-Cognitive Correlates of Pediatric Anxiety Disorders

Official study title

Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders

Multiple locations, including Bethesda
Depression, AnxietyMedication studyAges 8–65
Countries
United States
Sponsor
National Institute of Mental Health (NIMH) (Government agency)
Drug study icon
RecruitingNCT07520292

NTX-2001 on Alcohol Consumption in Addiction

Official study title

The Effects of NTX-2001, a Novel TAAR1 Partial Agonist, on Alcohol Consumption in Adults With Alcohol Use Disorder: A Phase 1b, Randomized, Placebo-Controlled, Proof-of-Concept Study

In New Haven
AddictionMedication studyAges 21–60
Countries
United States
Sponsor
Newleos Therapeutics, Inc.
Other study type icon
RecruitingNCT04945278

Self-recognition and sense of self in people vulnerable to psychosis

About this title

Study of Self-Recognition and Self/Other Distinction Disorders in Patients With Psychological Vulnerability

Read the official source — NCT04945278
Official study title

Study of Self-Recognition and Self/Other Distinction Disorders in Patients With Psychological Vulnerability (ALTER EGO)

In Bohars
SchizophreniaInterventional studyAges 15–25
Countries
France
Sponsor
University Hospital, Brest

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.